Enable JavaScript to visit this website.


XELJANZ/XELJANZ XR (tofacitinib) is a prescription medicine called a Janus kinase (JAK) inhibitor used to treat:

  • Adults with active psoriatic arthritis in which methotrexate or other similar medicines called nonbiologic disease-modifying antirheumatic drugs (DMARDs) did not work well.

It is not known if XELJANZ/XELJANZ XR is safe and effective in children or in people with Hepatitis B or C.

XELJANZ/XELJANZ XR is not recommended for people with severe liver problems.

If you no longer wish to receive information or updates about XELJANZ/XELJANZ XR for your active psoriatic arthritis, please enter your email address below and we will remove you from our contact list


For more information or assistance, please Contact Us.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.